PH and HIV
Recorded on Dec. 8, 2021
As human immunodeficiency virus (HIV) treatments improve and patients live longer, more people with HIV are developing cardiovascular diseases, including pulmonary arterial hypertension (PAH). Christopher F. Barnett, M.D., M.P.H., discusses the risk for developing PAH in people with HIV, how it is diagnosed and current treatment options.
About the Speaker
Christopher F. Barnett, M.D., M.P.H
Christopher F. Barnett, M.D., M.P.H., is professor of clinical medicine at the University of California, San Francisco. Dr. Barnett earned his medical degree at Northwestern University and completed his residency in internal medicine at Northwestern Memorial Hospital. He completed a clinical and research fellowship in critical care medicine at the National Institutes of Health followed by a cardiology fellowship at the University of San Diego. Dr. Barnett has run pulmonary hypertension (PH) patient support groups and has been actively involved with PHA since 2011.
Free brochure: “Pulmonary Hypertension and HIV”
PHA thanks Janssen Pharmaceuticals for its Diamond sponsorship of the Associated Disease Outreach & Engagement Program, which provides support to this PHA Live event.